Stay updated on Neo-Pembrolizumab + Androgen Blockade in Prostatectomy Clinical Trial
Sign up to get notified when there's something new on the Neo-Pembrolizumab + Androgen Blockade in Prostatectomy Clinical Trial page.

Latest updates to the Neo-Pembrolizumab + Androgen Blockade in Prostatectomy Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedVersion bump to v3.2.0 with a government funding lapse notice; previous v3.1.0 reference removed.SummaryDifference4%
- Check24 days agoChange DetectedAdds updated contact details and a new revision identifier (v3.1.0); removes the Prostate cancer topic from MedlinePlus Genetics and references an older revision (v3.0.2).SummaryDifference0.4%
- Check31 days agoChange DetectedAdded MedlinePlus Genetics topic: Prostate cancer. No deletions observed.SummaryDifference0.3%
- Check39 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2, indicating a patch-level update. The Back to Top link was removed, reducing navigation convenience but not affecting core content.SummaryDifference0.3%
- Check46 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.3%
- Check53 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as new medical terms related to Parkinson's disease and specific drugs like pembrolizumab and enzalutamide. Notably, previous location details and various medical topics have been removed.SummaryDifference3%
Stay in the know with updates to Neo-Pembrolizumab + Androgen Blockade in Prostatectomy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neo-Pembrolizumab + Androgen Blockade in Prostatectomy Clinical Trial page.